These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Introduction: new insights on enhancing adherence to topical glaucoma medications. Friedman DS Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257 [No Abstract] [Full Text] [Related]
7. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Hahn SR Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259 [TBL] [Abstract][Full Text] [Related]
8. A clinician's guide to the assessment and management of nonadherence in glaucoma. Budenz DL Ophthalmology; 2009 Nov; 116(11 Suppl):S43-7. PubMed ID: 19837260 [TBL] [Abstract][Full Text] [Related]
9. Should patients choose their own eyedrops? Buller A; Hercules BL Acta Ophthalmol Scand; 2006 Feb; 84(1):150-1. PubMed ID: 16445459 [No Abstract] [Full Text] [Related]
14. Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications. Schwartz GF; Platt R Am J Manag Care; 2002 Aug; 8(10 Suppl):S278-80. PubMed ID: 12188171 [TBL] [Abstract][Full Text] [Related]
15. Part I. Patient administration of eyedrops: interview. Kass MA; Hodapp E; Gordon M; Kolker AE; Goldberg I Ann Ophthalmol; 1982 Aug; 14(8):775-9. PubMed ID: 7125474 [TBL] [Abstract][Full Text] [Related]
16. A labelling method for eyedrops to improve compliance. Ritch R; Liebmann J; Steinberger D Ophthalmic Surg; 1993 Dec; 24(12):861. PubMed ID: 8115108 [No Abstract] [Full Text] [Related]
17. Will improvement of knowledge lead to improvement of compliance with glaucoma medication? Mansouri K; Shaarawy T Acta Ophthalmol; 2009 Jun; 87(4):468-9; author reply 469-71. PubMed ID: 19416109 [No Abstract] [Full Text] [Related]
18. Successful topical medication: methodology as well as diligence. Zimmerman TJ; Ziegler LP Ann Ophthalmol; 1984 Feb; 16(2):109. PubMed ID: 6703581 [No Abstract] [Full Text] [Related]
19. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Dasgupta S; Oates V; Bookhart BK; Vaziri B; Schwartz GF; Mozaffari E Am J Manag Care; 2002 Aug; 8(10 Suppl):S255-61. PubMed ID: 12188168 [TBL] [Abstract][Full Text] [Related]
20. Topical estrogen drops for glaucoma? A long way to go. Yin H; Liu X Med Hypotheses; 2008; 70(5):1069. PubMed ID: 18178012 [No Abstract] [Full Text] [Related] [Next] [New Search]